Navigation Links
New consensus on work-related asthma

In a new consensus statement, the American College of Chest Physicians offers guidance on the diagnosis and treatment of work-related asthma (WRA), a chronic respiratory condition that includes occupational asthma and work-exacerbated asthma (WEA) and affects as many as 25 percent of adults with asthma. Published as a supplement to the September issue of CHEST, the consensus statement, updated from 1995, places new emphasis on

  1. preventive measures, including better control of exposures;
  2. the need for a combination of diagnostic testing; and
  3. the importance of obtaining a full medical and occupational history in patients with suspected WRA.

The statement also places greater consideration on the diagnosis and management of WEA, which is preexisting or concurrent asthma that is worsened by work-related conditions. Developed by an expert panel of specialists in allergy, pulmonary medicine, and occupational medicine, the consensus statement provides supplemental materials, including a worker/workplace fact sheet and physician flow sheets to help physicians and other health-care providers diagnose and manage WRA. For more information related to the ACCP consensus statement on work-related asthma, visit


Contact: Jennifer Stawarz
American College of Chest Physicians

Page: 1

Related biology technology :

1. Expert Consensus Panel Recommendation for Incorporating Lp-PLA2 Testing into Cardiovascular Disease Risk Assessment Guidelines
2. International Wound Care Experts, Medline Announce Pressure Ulcer Prevention Consensus Paper
3. Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11
4. New Patient Satisfaction Study With budesonide/formoterol Combination Therapy and fluticasone/salmeterol Combination Therapy in Adults With Asthma
5. Asthma Uncontrolled in More Than 40 Percent of Adults With the Disease, New Landmark Survey Shows
6. Asthma Patients Not Adequately Controlled on ICS Alone More Likely to Benefit From Advair(R) Than Doubling the Dose of ICS
7. Apieron, Inc. Announces FDA Clearance of the Insight(TM) eNO System to Assist Physicians with Patient Asthma Management
8. Allergy Standards LTD to Attend 2008 American Academy of Allergy, Asthma and Immunology Conference
9. FDA Grants Market Clearance to Aerocrine Inc.s NIOX MINO(R): a New Hand-Held Device to Measure Airway Inflammation in Asthma
10. Drug Reduces Airway Mucus in Preclinical Asthma Model
11. AIM-Quoted Verona Pharma Progresses Anti-Asthma Drug Studies
Post Your Comments:
(Date:11/25/2015)... Mass. , Nov. 25, 2015 Harvard ... biotechnology company developing bioengineered organ implants for life-threatening conditions, ... present at the LD Micro "Main Event" investor conference ... The presentation will be webcast live and posted for ... be available at the conference for one-on-one meetings on ...
(Date:11/25/2015)... , Nov. 25, 2015 /PRNewswire/ - Aeterna Zentaris ... that its business and prospects remain fundamentally strong ... Zoptrex™ (zoptarelin doxorubicin) recently received DSMB recommendation to ... completion following review of the final interim efficacy ... 2 Primary Endpoint in men with heavily pretreated ...
(Date:11/25/2015)... , Nov. 25, 2015 Orexigen® Therapeutics, ... will participate in a fireside chat discussion at the ... New York . The discussion is scheduled for ... .  A replay will be available ... Contact:McDavid Stilwell  , Julie NormartVP, Corporate Communications and ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... company uBiome, were featured on AngelList early in their initial angel funding process. ... AngelList syndicate for individuals looking to make early stage investments in the microbiome ...
Breaking Biology Technology:
(Date:11/10/2015)... , Nov. 10, 2015  In this ... the basis of product, type, application, disease ... in this report are consumables, services, software. ... are safety biomarkers, efficacy biomarkers, and validation ... report are diagnostics development, drug discovery and ...
(Date:11/4/2015)... , November 4, 2015 ... new market report published by Transparency Market Research "Home Security ... Trends and Forecast 2015 - 2022", the global home security ... 30.3 bn by 2022. The market is estimated to ... period from 2015 to 2022. Rising security needs among ...
(Date:10/29/2015)... -- Daon, a global leader in mobile biometric authentication ... version of its IdentityX Platform , IdentityX v4.0. ... have already installed IdentityX v4.0 and are seeing ... UAF certified server component as an option and ... These customers include some of the largest and most ...
Breaking Biology News(10 mins):